Consequently, loss of BRCA1 is synthetic lethal to cells harbouring CCNE1 amplifications, and this has recently been validated using inhibition of BRCA1-mediated DNA repair in ovarian cancer cell lines [53]. This evidence concerns the gene CCNE1 and ovarian cancer.